SCMP
Sucampo Pharmaceuticals, Inc.
SCMP
SCMP
Delisted
SCMP was delisted on the 12th of February, 2018.
134 hedge funds and large institutions have $220M invested in Sucampo Pharmaceuticals, Inc. in 2016 Q1 according to their latest regulatory filings, with 20 funds opening new positions, 54 increasing their positions, 44 reducing their positions, and 34 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
134
Holders Change
-15
Holders Change %
-10.07%
% of All Funds
3.58%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
20
Increased
54
Reduced
44
Closed
34
Calls
$1.85M
Puts
$467K
Net Calls
+$1.38M
Net Calls Change
+$1.18M
Top Buyers
| 1 |
Renaissance Technologies
New York
|
+$2.96M |
| 2 |
Morgan Stanley
New York
|
+$2.24M |
| 3 |
QI
QS Investors
New York
|
+$2.2M |
| 4 |
Boston Partners
Boston,
Massachusetts
|
+$1.91M |
| 5 |
MCM
McKinley Capital Management
Anchorage,
Alaska
|
+$1.52M |
Top Sellers
| 1 |
State Street
Boston,
Massachusetts
|
-$7.51M |
| 2 |
WRF
Waddell & Reed Financial
Overland Park,
Kansas
|
-$3.33M |
| 3 |
GAM
Gotham Asset Management
New York
|
-$3.27M |
| 4 |
Prudential Financial
Newark,
New Jersey
|
-$3.13M |
| 5 |
Invesco
Atlanta,
Georgia
|
-$2.99M |
